Effectiveness evaluation survey for Eurartesim

Study type

• Study topic:
  Other
• Study topic, other:
  Disease/Epidemiology study, Effectiveness evaluation of the education material provided about Eurartesim™
• Study type:
  Non-interventional study
• Scope of the study:
  Effectiveness study (incl. comparative)
• Data collection methods:
  Primary data collection

Non-interventional study

• Non-interventional study design:
  Other
• Non-interventional study design, other:
  Survey study (questionnaire)

Population studied

• Short description of the study population:
  Physicians who were expected to prescribe or use Eurartesim for the treatment of malaria and who were delivered Eurartesim™ education material.; ; Inclusion criteria:; 1. Physicians known to treat and follow-up patients with malaria; 2. Physicians not participating in Pregnancy and Safety registries; 3. Physicians who agree to participate in the survey
• Age groups:
  Children (2 to < 12 years)

  Adolescents (12 to < 18 years)

  Adults (18 to < 46 years)

  Adults (46 to < 65 years)

  Adults (65 to < 75 years)

  Adults (75 to < 85 years)

  Adults (85 years and over)
• Estimated number of subjects:
  0

Study design details

• Main study objective:
  To ascertain the physician understanding of the education material provided about Eurartesim, in terms of drug indication, prescription modalities, administration modalities, high-risk patients, and potential side effects.
• Data analysis plan:
  Continuous variables will be described by their mean, standard deviation, median, quartiles 1 and 3, extreme values (minimum and maximum) and the number of missing data.Categorical variables will be described by the total and percentage of each response and the number of missing data. 95% confidence intervals will be computed on each individual percentage.Description of the study population:Characteristics of participating Physicians will be described.Response to the primary objective:- Knowledge of indication of Eurartesim will be described- Knowledge of prescription modalities of Eurartesim will be described- Knowledge of administration modalities of Eurartesim will be described- Knowledge of effects on cardiac repolarization will be described- Knowledge of high-risk patients will be described- Knowledge of potential side effects of Eurartesim will be described- Awareness of the pregnancy and safety registries and available information